WELL announces the launch of WELL AI Decision Support, to assist healthcare providers in improving early disease diagnosis and preventative health.

WELL宣布推出人工智能决策支持，协助医疗服务提供者改善早期疾病诊断和预防性健康。

WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis to power its solutions both in Canada and the US.

WELL完全与HEALWELL AI合作，HEALWELL AI是AI启用疾病诊断的领导者，为加拿大和美国的解决方案提供动力。

WELL's goal is to make AI Enabled Decision Support a core offering to all physicians supported by its fully managed and SaaS platforms which collectively power more than 31,000 physicians and other care providers across Canada and the US.

WELL的目标是为所有医生提供AI支持的决策支持核心服务，这些医生由其全面管理的SaaS平台支持，这些平台共同为加拿大和美国的31000多名医生和其他护理提供者提供支持。

Since October 1, 2023, HEALWELL AI has closed $18 million in financing including a $10 million convertible debenture round lead by WELL Health, who is now the largest equity shareholder of HEALWELL AI, on an as converted basis.

自2023年10月1日起，HEALWELL AI已关闭1800万美元的融资，其中包括WELL Health领导的1000万美元可转换债券，WELL Health现已成为HEALWELL AI的最大股权股东。

VANCOUVER, BC and TORONTO, Oct. 18, 2023 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ('WELL') a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI (TSX: AIDX) ('HEALWELL'), are pleased to announce the launch of 'WELL AI Decision Support', a groundbreaking new service for healthcare providers.

温哥华，不列颠哥伦比亚省和多伦多，2023年10月18日/PRNewswire/-WELL Health Technologies Corp.（TSX:WELL）（OTCQX:WHTCF）（'WELL'）一家专注于技术支持医疗保健提供者的数字健康公司，以及它的投资公司HEALWELL AI（TSX:AIDX）（'HEALWELL'）很高兴宣布启动'WELL AI决策支持'，这是一项为医疗保健提供者开创性的新服务。

This partnership is the first major collaborative initiative between the two companies since the announcement of the Strategic Alliance Agreement on October 3, 2023. Both companies view this as the beginning of a long-term, mutually beneficial partnership, with a shared vision and commitment to ongoing innovation..

自2023年10月3日战略联盟协议公布以来，这家合作伙伴关系是两家公司之间的第一项重大合作举措。两家公司都将此视为长期互利合作的开始，共同愿景并承诺持续创新。。

Hamed Shahbazi, Founder and CEO of WELL commented, 'We firmly believe the physician experience of the not-too-distant future will involve a number of safe, secure and helpful digital diagnostic tools that will better support healthcare providers in detecting acute and chronic diseases earlier.  The launch of 'WELL AI Decision Support' perfectly aligns with our core strategy to empower healthcare providers with transformative technology, enhancing their capacity to improve patient outcomes and promote preventative health.'.

WELL的创始人兼首席执行官Hamed Shahbazi评论说：“我们坚信，在不远的将来，医生的经验将涉及许多安全，安全和有用的数字诊断工具，这些工具将更好地支持医疗保健提供者更早地检测急慢性疾病。“良好人工智能决策支持”的启动与我们的核心战略完全一致，即为医疗保健提供者提供变革性技术，增强他们改善患者预后和促进预防性健康的能力。

Dr. Michael Frankel, Chief Medical Officer of WELL, added, 'The arrival of 'WELL AI Decision Support' marks more than just technological advancement; it's a watershed moment in our pursuit of superior patient care. By harnessing AI's potential, we are equipping healthcare professionals with tools that refine and elevate their practice.

WELL的首席医疗官Michael Frankel博士补充说，“良好的人工智能决策支持”的到来不仅仅标志着技术进步；这是我们追求卓越患者护理的分水岭。通过利用人工智能的潜力，我们为医疗保健专业人员配备了改进和提升其实践的工具。

Each patient deserves individualized attention and precision in care, and this module is a step forward in realizing that vision.'.

每位患者都应该在护理中获得个性化的关注和精确度，这个模块是实现这一愿景的一个进步。

Dr. Alexander Dobranowski, CEO of HEALWELL AI, said, ' Our partnership with WELL is a strategic imperative in healthcare. The alignment between HEALWELL's pioneering data science and WELL's expansive clinical network underscores the strength of our collaboration. Together, with WELL's robust healthcare software solutions, we are creating a synergy poised to redefine healthcare standards.

HEALWELL AI首席执行官Alexander Dobranowski博士说：“我们与WELL的合作关系是医疗保健的战略当务之急。HEALWELL开创性的数据科学与WELL广泛的临床网络之间的一致强调了我们合作的实力。与WELL强大的医疗保健软件解决方案一起，我们正在创建一个旨在重新定义医疗保健标准的协同作用。

This partnership amplifies our combined commitment to leveraging data science for healthcare applications, ultimately benefiting patients and healthcare providers alike.'.

这种合作关系扩大了我们将数据科学用于医疗保健应用的共同承诺，最终使患者和医疗保健提供者受益。

The 'WELL AI Decision Support' module is a groundbreaking solution that bridges a critical gap in healthcare diagnostics and patient care, heralding a new era of precision in healthcare delivery. WELL AI Decision Support leverages artificial intelligence (AI) technologies to enable the earlier diagnosis, treatment and improved quality of life for the patient.

“良好的AI决策支持”模块是一项开创性的解决方案，弥合了医疗诊断和患者护理方面的关键差距，预示着医疗服务精确性的新时代。人工智能决策支持利用人工智能（AI）技术为患者提供早期诊断，治疗和改善生活质量。

The technology behind WELL AI Decision Support has been meticulously developed by HEALWELL, in close collaboration with dedicated physicians, leading researchers, data privacy professionals, pharmaceutical companies, and other domain experts. This rigorous process of development and refinement has led to its validation in both Canadian and U.S.

HEALWELL与专职医生，领先研究人员，数据隐私专业人员，制药公司和其他领域专家密切合作，精心开发了人工智能决策支持背后的技术。这种严格的发展和完善过程已导致其在加拿大和美国的验证。

healthcare systems. WELL AI Decision Support is also a highly modular service that will be expanded with time.  Initially, the service enables healthcare providers to accurately identify over 110 complex or rare diseases often overlooked by traditional methods, providing hope to thousands of patients across Canada..

医疗系统。人工智能决策支持也是一项高度模块化的服务，将随着时间的推移而扩展。最初，该服务使医疗保健提供者能够准确识别传统方法经常忽视的110多种复杂或罕见疾病，为加拿大各地的数千名患者提供希望。。

'WELL AI Decision Support' is the second significant product release under the WELLHealth.ai program, following the successful 'WELL AI Voice' module, and further exemplifies WELL's unwavering commitment and leadership in delivering effective AI solutions in healthcare. WELL AI Decision Support is featured on apps.health, WELL's premium digital marketplace for EMR tools and applications..

“WELL AI决策支持”是WELLHealth.AI计划下的第二个重要产品版本，紧随成功的“WELL AI Voice”模块之后，进一步体现了WELL在医疗保健领域提供有效AI解决方案的坚定承诺和领导力。WELL AI决策支持在apps.health，WELL的EMR工具和应用程序高级数字市场上提供。。

Rare and complex diseases affect over 300 million patients worldwide, and in Canada, 1 in 12 individuals lives with a rare disorder. What's even more alarming is the substantial number of people who remain undiagnosed and unaware of their underlying conditions. For those who do exhibit symptoms, the journey to a correct diagnosis is an arduous one.

罕见和复杂的疾病影响全球3亿多患者，在加拿大，每12个人中就有1个人患有罕见疾病。更令人担忧的是，仍有大量未被诊断且未意识到其潜在状况的人。对于那些确实表现出症状的人来说，进行正确诊断的过程非常艰巨。

On average, they consult 8 physicians, endure 2-3 misdiagnoses over a span of 4.8yrs before receiving an accurate diagnosis..

平均而言，他们咨询了8位医生，在接受准确诊断之前忍受了4.8年的2-3次误诊。。

This partnership represents a significant win for HEALWELL, granting expansive channel access to healthcare providers. The launch of 'WELL AI Decision Support' module underscores the trust and validation of HEALWELL's expertise within the industry. Both WELL and HEALWELL plan to continue to collaborate to combine their expertise and capabilities for more groundbreaking developments in the future..

这种合作关系为HEALWELL带来了巨大的胜利，为医疗保健提供者提供了广泛的渠道。“良好人工智能决策支持”模块的推出强调了HEALWELL在行业内的专业知识的信任和验证。WELL和HEALWELL都计划继续合作，将他们的专业知识和能力结合起来，以实现未来更具开创性的发展。。

For detailed insights into WELL AI Decision Support, please visit https://decisionsupport.wellhealth.ai/.

有关人工智能决策支持的详细见解，请访问https://decisionsupport.wellhealth.ai/.

WELL HEALTH TECHNOLOGIES CORP.

健康技术公司。

Per: 'Hamed Shahbazi'

收件人：“Hamed Shahbazi”

Hamed Shahbazi

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

首席执行官，主席兼董事

About WELL Health Technologies Corp.

关于健康技术公司。

WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices.

WELL的使命是技术支持医疗保健提供者。我们通过开发可用的最佳技术，服务和支持来实现这一目标，确保医疗服务提供者有权对患者结果产生积极影响。WELL的综合医疗保健和数字平台包括广泛的前后办公室管理软件应用程序，帮助医生运行和保护他们的实践。

WELL's solutions enable more than 31,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 148 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health.

WELL的解决方案使美国和加拿大之间的31000多家医疗保健提供者成为加拿大最大的拥有和运营的医疗保健生态系统，拥有148多家诊所，支持初级保健，专业护理和诊断服务。在美国，WELL的解决方案集中在专业市场，如胃肠市场，女性健康，初级保健和心理健康。

WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about WELL, please visit: www.well.company..

WELL在多伦多证券交易所以“WELL”符号公开交易，在场外交易所以“WHTCF”符号公开交易。要了解更多关于好的信息，请访问：www.WELL.company。。

About HEALWELL AI Inc.

关于HEALWELL AI Inc。

HEALWELL AI is a health care technology company focused on AI and data science for preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. As a physician-led organization with a proven management team of experienced executives, HEALWELL AI is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the company's road map.

HEALWELL AI是一家专注于AI和数据科学预防保健的医疗保健技术公司。其使命是通过及早发现和发现疾病来改善医疗保健并挽救生命。作为一家由经验丰富的高管组成的以医生为主导的组织，HEALWELL AI正在执行一项以开发和获取技术和临床科学能力为中心的战略，以补充公司的路线图。

HEALWELL AI is publicly traded on the Toronto Stock Exchange under the symbol AIDX. To learn more about HEALWELL AI, please visit: https://healwell.ai/..

HEALWELL AI在符号AIDX下在多伦多证券交易所公开交易。要了解有关HEALWELL AI的更多信息，请访问：https://healwell.ai/..

Forward-Looking Statements

前瞻性声明

This news release may contain 'Forward-Looking Information' within the meaning of applicable Canadian securities laws, including, without limitation: information regarding WELL and HEALWELL's goals, strategies, and growth plans, including plans to collaborate and deploy new AI technologies; future voting rights and control, and expectations regarding revenue and EBITDA.

本新闻稿可能包含适用的加拿大证券法含义内的“前瞻性信息”，包括但不限于：有关WELL和HEALWELL目标，策略和成长计划的信息，包括合作和部署新AI技术的计划；未来的投票权和控制权，以及对收入和EBITDA的期望。

Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic, and competitive uncertainties and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as 'may', 'should', 'will', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations.

前瞻性信息必然基于一系列估计和假设，尽管管理层认为这些估计和假设是合理的，但本质上会受到重大的业务，经济和竞争不确定性和意外事件的影响。前瞻性信息通常可以通过使用前瞻性词语来识别，例如“可能”，“应该”，“将会”，“可能”，“意图”，“估计”，“计划”，“预期”，“期望”，“相信”或“继续”，或其负面或类似的变化。

Forward-Looking Information involves known and unknown risks, uncertainties, and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance, or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance.

前瞻性信息涉及已知和未知的风险，不确定性以及可能导致未来结果，绩效或成就与预期信息表达或暗示的预期未来结果，绩效或成就大不相同的其他因素。信息不能保证未来的表现。

WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from the COVID-19 pandemic; adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative.

WELL由这些前瞻性信息表达或暗示的评论受到许多风险，不确定性和条件的影响，其中许多风险，不确定性和条件超出了WELL的控制范围，不应过度依赖这些信息。前瞻性信息通过固有的风险和不确定性全面限定，包括：COVID-19大流行的直接和间接物质不利影响；不利的市场条件；一般初级卫生保健部门固有的风险；监管和立法。

SOURCE WELL Health Technologies Corp.

源井健康技术公司。